Toggle navigation
Categories
Home
India
Latest News
Gujarat News
Horoscope
All India
World News
Latest World News
News in Hindi
News in Gujarati
Travel Tips
All World News
Business News
India Business News
Stock Market News
Share Market Tips
News in Hindi
Mobile News
All Business News
Sports
Latest Sports News
Sports News in Hindi
All Sports
Entertainment
News in English
News in Hindi
Daily Deals
All Entertainment
Health
World News
India News
All Health
Videos
Indian Food Recipes
Live News
Funny Video
Sadhguru - Yoga, Meditation & Spirituality
Yoga for Beginners – Daily Yoga Workout at Home
Informative Videos
Ayurvedic Upchar
All Videos
Music
BLOG
Home
/
1
Business News
/
1
Stock Market News
/
1
Sun Pharma’s steady India business and US specialty portfolio should help it do well in FY22
1
Sun Pharma’s steady India business and US specialty portfolio should help it do well in FY22
2020-8-3 10:00 am
Business News
→
Stock Market News
33
0
0
What adds to the Sun Pharma#39;s investment case is the prospect for US specialty. The management hopes to achieve EBITDA break-even for a few products next fiscal
pharmaa
steady
india
business
specialty
portfolio
should
E-Mail
Facebook
LinkedIn
Twitter
Pinterest
VK
Prev
What should investors do with Tata Motors: buy,...
Next
Agri Picks Report: Geojit
You May Also Like
Ageing dams in India, US, other nations pose...
Inside the world's biggest vaccine factory,...
Strong India following Netaji#39;s footsteps,...
150 people infected with UK variant of Covid-19...
Sports Authority of India to ensure intensity...
Sri Lanka to receive COVID-19 vaccines from...
1
IPL: पंजाब ने ग्लेन मैक्सवेल को किया रिलीज, लोकेश राहुल ही संभालेंगे कप्तानी
2
वर्ल्ड टेस्ट चैंपियनशिप: इंग्लैंड से सीरीज हारा तो फाइनल में नहीं पहुंचेगा भारत
3
IPL 2021: चेन्नै सुपर किंग्स से भज्जी, जाधव रिलीज, रैना रिटेन, अब ऐसी है टीम
4
The Despicables
5
IPL नहीं खेलेंगे यॉर्कर किंग लसिथ मलिंगा, फ्रैंचाइजी क्रिकेट से लिया रिटायरमेंट